Dataset Information

Making BREAD: Biomimetic Strategies for Artificial Intelligence Now and in the Future.

ABSTRACT: The Artificial Intelligence (AI) revolution foretold of during the 1960s is well underway in the second decade of the twenty first century. Its period of phenomenal growth likely lies ahead. AI-operated machines and technologies will extend the reach of Homo sapiens far beyond the biological constraints imposed by evolution: outwards further into deep space, as well as inwards into the nano-world of DNA sequences and relevant medical applications. And yet, we believe, there are crucial lessons that biology can offer that will enable a prosperous future for AI. For machines in general, and for AI's especially, operating over extended periods or in extreme environments will require energy usage orders of magnitudes more efficient than exists today. In many operational environments, energy sources will be constrained. The AI's design and function may be dependent upon the type of energy source, as well as its availability and accessibility. Any plans for AI devices operating in a challenging environment must begin with the question of how they are powered, where fuel is located, how energy is stored and made available to the machine, and how long the machine can operate on specific energy units. While one of the key advantages of AI use is to reduce the dimensionality of a complex problem, the fact remains that some energy is required for functionality. Hence, the materials and technologies that provide the needed energy represent a critical challenge toward future use scenarios of AI and should be integrated into their design. Here we look to the brain and other aspects of biology as inspiration for Biomimetic Research for Energy-efficient AI Designs (BREAD).

SUBMITTER: Krichmar JL

PROVIDER: S-EPMC6610536 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Making BREAD: Biomimetic Strategies for Artificial Intelligence Now and in the Future.

Krichmar Jeffrey L JL Severa William W Khan Muhammad S MS Olds James L JL

Frontiers in neuroscience 20190627

The Artificial Intelligence (AI) revolution foretold of during the 1960s is well underway in the second decade of the twenty first century. Its period of phenomenal growth likely lies ahead. AI-operated machines and technologies will extend the reach of Homo sapiens far beyond the biological constraints imposed by evolution: outwards further into deep space, as well as inwards into the nano-world of DNA sequences and relevant medical applications. And yet, we believe, there are crucial lessons t ...[more]

PMID: 31316340

Similar Datasets

Project description:The healthcare industry, and specifically the pharmacovigilance industry, recognizes the need to support the increasing amount of data received from individual case safety reports (ICSRs). To cope with this increase, more healthcare and qualified professionals are required to capture and evaluate the data. To address the evolving landscape, it will be necessary to embrace assistive technologies such as artificial intelligence (AI) at scale. AI in the field of pharmacovigilance will possibly result in the transformation of the drug safety (DS) professional's daily work life and their career development. Celgene's Global Drug Safety and Risk Management (GDSRM) function has established a series of work activities to drive innovation across the pharmacovigilance value chain (Celgene Chrysalis Fact Sheet. https://www.celgene.com/newsroom/media-library/chrysalis-fact-sheet/, 2018). The development of AI in pharmacovigilance raises questions about the possible changes in DS professionals' lives, who may find themselves curious about their future roles in a workplace assisted by AI. We discuss the current state of pharmacovigilance and the DS professional, AI in pharmacovigilance and the potential skillsets a DS professional may require when working with AI. We also describe the results of research conducted at Celgene GDSRM. The objective of the research was to understand the thoughts of pharmacovigilance professionals about their jobs. These results are provided in the form of aggregated responses to interview questions based on a 12-part questionnaire [see the Electronic Supplementary Material (ESM)]. A sample of six DS professionals representing various areas of pharmacovigilance operations were asked a range of questions about their backgrounds, current roles and future expectations. The DS professionals interviewed were, overall, enthusiastic about their job roles potentially changing with AI enhancements. Interviewees suggested that AI would allow for pharmacovigilance resources, time, and skills to shift the work from a volume-based to a value-based focus. The results suggest that pharmacovigilance professionals wish to use their qualifications, skillsets and experience in work that provides more value for their efforts. Machine learning algorithms have the potential to enhance DS professionals' decision-making processes and support more efficient and accurate case processing.

Dataset Information

Making BREAD: Biomimetic Strategies for Artificial Intelligence Now and in the Future.

Publications

Making BREAD: Biomimetic Strategies for Artificial Intelligence Now and in the Future.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets